LONG BEACH, California — Percutaneous coronary intervention procedures performed using the radial artery in the arm have almost tripled in the past decade, according to a new study evaluating 6.7 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PCI improved angina symptoms at 12 weeks vs. a sham ...

Regulators are on board and the reimbursement is there, but should more complex percutaneous coronary intervention (PCI) procedures be shifted from a traditional hospital setting to an ambulatory ...

As the demand for cardiac care in the US continues to rise, and as more patients are screened and treated for cardiovascular disease, cardiac catheterization and percutaneous coronary intervention ...

WASHINGTON, DC—Complex high-risk indicated PCI procedures (CHIP)—such as chronic total occlusions (CTOs) or calcified lesions—can be safely performed by fellows in training, according to new ...

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous ...

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, ...

SAN DIEGO, CA — Routine thrombectomy with PCI for acute ST-elevation MI (STEMI) does not confer an advantage in CV death, recurrent MI, shock, or severe heart failure over 6 months compared with ...

Please provide your email address to receive an email when new articles are posted on . Registry data show transradial access was used for most patients who underwent complex, high-risk PCI.

Now that CMS has approved reimbursement for percutaneous coronary interventions (PCIs), among other cardiovascular procedures, in the ambulatory surgery center (ASC) setting, Medicare-accredited ...

Researchers suggest same-day discharge after elective percutaneous coronary intervention, such as stent placement, was not associated with a higher risk of readmission or mortality, but few providers ...

NATICK, Mass. Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous Robotic-Enhanced Coronary ...